News
Keir Starmer has been mocked for claiming he was too distracted by foreign affairs to realise he was facing a huge Labour rebellion over welfare cuts. The prime minister has held his hands up to a ...
Gilead officials lauded the FDA's approval of lenacapavir, which has been studied and developed over nearly two decades. "We now have a very real opportunity to end the HIV epidemic," said Daniel ...
The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday.
Here’s what everyone should know about this new HIV prevention shot Yeztugo, a twice-a-year shot approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year ...
Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.
HIV is the acronym for human immunodeficiency virus. HIV can only spread through bodily fluids like breast milk, blood, semen, pre-cum, rectal fluids, and vaginal fluids. The initial symptoms of ...
Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...
A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results